Mitotane: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Mitotane. Educational only — not medical advice.
Labeled uses
LYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC).
Source: FDA labeling via NIH DailyMed (set f0cd76e9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.